References

Barrett B. Medicinal properties of Echinacea: a critical review. Phytomedicine 10.1 (2003): 66-86.

Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 48.8 (1999): 62835.

Barrett BP et al. Treatment of the common cold with unrefined Echinacea: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 137.12 (2002): 939-46.

Bauer VR et al. Immunologic in vivo and in vitro studies on Echinacea extracts. Arzneimittelforschung 38.2 (1988): 276-81.

Binns SE et al. Light-mediated antifungal activity of Echinacea extracts. Planta Med 66.3 (2000): 241-4.

Binns SE et al. Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I). Planta Med 68.9 (2002): 780-3.

Blumenthal M, Goldberg A, Brinckmann J (eds). Herbal Medicine: Expanded Commission E Monographs. Austin, TX: Integrative Medicine Communications, 2000.

Brousseau M, Miller SC. Enhancement of natural killer cells and increased survival of aging mice fed daily Echinacea root extract from youth. Biogerontology 6.3 (2005): 157-63.

Clifford LJ et al. Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench. Phytomedicine 9.3 (2002): 249-53.

Cohen HA et al. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med 158.3 (2004): 217-21.

Di Carlo G et al. Modulation of apoptosis in mice treated with Echinacea and St John's wort. Pharmacol Res 48.3 (2003): 273-7.

Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136.1 (2002): 42-53.

Gallo M et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med 160.20 (2000): 3141-3.

Gleeson M, Lancaster GI, Bishop NC. Nutritional strategies to minimise exercise-induced immunosuppression in athletes. Can J Appl Physiol 26 (Suppl) (2001): S23-35.

Goel V et al. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 29.1 (2004): 75-83.

Gorski JC et al. The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 75.1 (2004): 89-100.

Gurley BJ et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 76.5 (2004): 428-40.

Hayashi I et al. Effects of oral administration of Echinacea purpurea (American herb) on incidence of spontaneous leukemia caused by recombinant leukemia viruses in AKR/J mice. Nihon Rinsho Meneki Gakkai Kaishi 24.1 (2001): 10-20.

Heikkinen T, Jarvinen A. The common cold. Lancet 361.9351 (2003): 51-9.

Kinkel HJ, Plate M, Tullner HU. Effect of Echinacin ointment in healing of skin lesions. Med Klin 1984; 79: 580-4; as cited in Micromedex Thomson 2003. www.micromedex.com.

Linde K et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 1 (2006): CD000530.

Meie hart D et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2 (2000): CD000530.

Meie hart D et al. Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract unde sired effects of chemotherapy: a pilot study. Phytother Res 16.2 (2002): 138-42.

Miller SC. Echinacea: a miracle herb against aging and cancer? Evidence in vivo in mice. Evid Based Complement Altern Med 2.3 (2005): 309-14.

Mills S, Bone K. Principles and Practice of Phytotherapy. London: Churchill Livingstone, 2000.

Mills S, Bone K. The Essential Guide to Herbal Safety. St Louis, MO: Churchill Livingstone, 2005.

Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol 88.1 (2002): 42-51.

Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust 168.4 (1998): 170-1.

PizzornoJ, Murray M. Textbook of Natural Medicine. St Louis: Elsevier, 2006.

Raduner S et al. Alkylamides from Echinacea are a new class of cannabinomimetics: Cannabinoid type 2

receptor-dependent and -independent immunomodulatory effects. J Biol Chem 281.20 (2006): 14192-206.

Raso GM et al. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J Pharm Pharmacol 54.10 (2002): 1379-83.

Roesler J et al. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system. Int J Immunopharmacol 13.7 (1991): 931-41.

Sc hoop Ret al. Echinacea in the prevention of induced rhino vir us colds: a meta-analysis. Clin Ther 28.2 (2006): 174-83.

Schulten B et al. Efficacy of Echinacea purpurea in patients with a common cold: A placebo-controlled, randomised, double-blind clinical trial. Arzneimittelforschung 51.7 (2001): 563-8.

Schwarz E et al. Oral administration of freshly expressed juice of Echinacea purpurea herbs fail to stimulate the nonspecific immune response in healthy young men: results of a double-blind, placebo-controlled crossover study. J Immunother 25.5 (2002): 413-20. Echinacea 380

Sharma M et al. Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Phytother Res 20.2 (2006): 147-52.

Spasov AA et al. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children. PhytotherRes 18.1 (2004): 47-53.

Sperber SJ et al. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin Infect Dis 38.10 (2004): 1367-71.

Speroni E et al. Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract. J Ethnopharmacol 79.2 (2002): 265-72.

Taylor JA et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 290.21 (2003): 2824-30.

Tragni E et al. Evidence from two classic irritation tests for an anti-inflammatory action of a natural extract, Echinacina B. Food Chem Toxicol 23.2 (1985): 317-19.

Tubaro A et al. Anti-inflammatory activity of a polysaccharidic fraction of Echinacea angustifolia. J Pharm Pharmacol 39.7 (1987): 567-9.

Turner RB, Riker DK, Gangemi JD. Ineffectiveness of echinacea for prevention of experimental rhinovirus colds. Antimicrob Agents Chemother 44.6 (2000): 1708-9.

Turner RB et al. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 353.4 (2005): 341-8.

Ulbricht CE, Bäsch EM. Natural Standard Herb and Supplement Reference. St Louis: Mosby, 2005.

Vonau B et al. Does the extract of the plant Echinacea purpurea influence the clinical course of recurrent genital herpes? Int J STD AIDS 12.3 (2001): 154-8.

Weber W et al. Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med 11.6 (2005): 1021-6.

Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, doubleblind, placebo-controlled clinical trial. Arch Intern Med 164.11 (2004): 1237-41.

Was this article helpful?

0 0
From Pain To Freedom

From Pain To Freedom

From Pain To Freedom is the Latest Scientific and Natural Medicine Breakthroughs to Understand and Relieve the Symptoms of Fibromyalgia!

Get My Free Ebook


Post a comment